Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 08/30
3040 INR   +1.91%
08/22 GLAXOSMITHKLINE : GSK and Save the Children initiate healthcare inno..
08/18 GlaxoSmithKline Sells Dermatology Foam Products Portfolio To Mayn..
08/16 GLAXOSMITHKLINE : Glaxo's ViiV Starts Phase 3 Trial On Two-Drug HIV-..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
08/24/2016 08/25/2016 08/26/2016 08/29/2016 08/30/2016 Date
3047(c) 3005(c) 2984.95(c) 2983(c) 3040 Last
11 444 14 145 12 888 5 939 4 603 Volume
-0.63% -1.38% -0.67% -0.07% +1.91% Change
More quotes
Financials ( INR)
Sales 2017 30 891 M
EBIT 2017 5 585 M
Net income 2017 4 460 M
Finance 2017 8 029 M
Yield 2017 1,86%
Sales 2018 35 213 M
EBIT 2018 7 220 M
Net income 2018 5 537 M
Finance 2018 4 453 M
Yield 2018 1,93%
P/E ratio 2017 53,00
P/E ratio 2018 44,15
EV / Sales2017 7,91x
EV / Sales2018 7,04x
Capitalization 252 351 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
08/22 GLAXOSMITHKLINE PHARMACEUTICALS : GSK and Save the Children initiate healthcare ..
08/18 GlaxoSmithKline Sells Dermatology Foam Products Portfolio To Mayne
08/16 GLAXOSMITHKLINE : Glaxo's ViiV Starts Phase 3 Trial On Two-Drug HIV-1 Treatment
08/01 EXTRA : Glaxo Teams With Alphabet's Verily On Bioelectronics Venture
08/01 TOP NEWS : Glaxo Teams With Alphabet's Verily On Bioelectronic Medicine
07/31 GLAXOSMITHKLINE PHARMACEUTICALS : GSK Pharma Q1 net down 23 per cent at Rs 72.27..
07/29 GLAXOSMITHKLINE PHARMACEUTICALS : GSK Pharma Q1 net down 23% at Rs 72.27 crore
07/29 GLAXOSMITHKLINE PHARMACEUTICALS : GSK PHARMA Q1 NET DOWN 23% AT Rs72.27 CRORE
07/27 Vectura Files Lawsuit Against Glaxo Over Option-To-Licence Agreement
07/27 GLAXOSMITHKLINE : Glaxo reports 2Q loss
More news
Sector news : Pharmaceuticals - NEC
08:49aDJBusiness Watch -- WSJ
08/29 Mylan to launch generic EpiPen at half the price of original
08/29DJMondelez Walks Away After Hershey Spurns Raised Bid
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test -- Update
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test
More sector news : Pharmaceuticals - NEC
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 14
Average target price 2 776  INR
Spread / Average Target -6,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Deepak Shantilal Parekh Non-Executive Chairman
Andrew Aristidou Chief Financial Officer & Executive Director
Raju Krishnaswamy Executive Director & Technical Director
Vrishali Desai Vice President-Medical & Clinical Research
D. Sundaram Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PHARMA..-9.55%3 762
JOHNSON & JOHNSON16.74%328 086
PFIZER INC.8.77%212 965
ROCHE HOLDING LTD.-12.84%212 954
NOVARTIS AG-10.83%208 887
MERCK & CO., INC.19.29%174 236
More Results